The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
Open accessAbstract
The cytochrome P450 (CYP) enzymes are major players in drug metabolism. More than 2,000 mutations have been described, and certain single nucleotide polymorphisms (SNPs) have been shown to have a large impact on CYP activity. Therefore, CYPs play an important role in inter-individual drug response and their genetic variability should be factored into personalized medicine. To identify the most relevant polymorphisms in human CYPs, a text mining approach was used. We investigated their frequencies in different ethnic groups, the number of drugs that are metabolized by each CYP, the impact of CYP SNPs, as well as CYP expression patterns in different tissues. The most important polymorphic CYPs were found to be 1A2, 2D6, 2C9 and 2C19. Thirty-four common allele variants in Caucasians led to altered enzyme activity. To compare the relevant Caucasian SNPs with those of other ethnicities a search in 1,000 individual genomes was undertaken. We found 199 non-synonymous SNPs with frequencies over one percent in the 1,000 genomes, many of them not described so far. With knowledge of frequent mutations and their impact on CYP activities, it may be possible to predict patient response to certain drugs, as well as adverse side effects. With improved availability of genotyping, our data may provide a resource for an understanding of the effects of specific SNPs in CYPs, enabling the selection of a more personalized treatment regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Human non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Genesis: cluster analysis of microarray data
Sturn, A., Quackenbush, J., & Trajanoski, Z. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.1.207 · Cited by 1,761
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Mega, J. L., Simon, T., Collet, J.-P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., et al. (2010) · JAMA · doi:10.1001/jama.2010.1543 · Cited by 1,135
Variability in Individual Responsiveness to Clopidogrel
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Alfonso, F., Macaya, C., Bass, T. A., & Costa, M. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.044 · Cited by 959
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Bradford, L. D. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.2.229 · Cited by 773
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Sibbing, D., Koch, W., Gebhard, D., Schuster, T., Braun, S., Stegherr, J., Morath, T., Schömig, A., von Beckerath, N., & Kastrati, A. (2010) · Circulation · doi:10.1161/circulationaha.109.885194 · Cited by 585
SDM--a server for predicting effects of mutations on protein stability and malfunction
Worth, C. L., Preissner, R., & Blundell, T. L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr363 · Cited by 565
Self-citationUsing photolabile ligands in drug discovery and development
Dormán, G., & Prestwich, G. D. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(99)01402-x · Cited by 425
Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Chemical Aspects of Selective Toxicity
ALBERT, A. (1958) · Nature · doi:10.1038/182421a0 · Cited by 401
Hulot, J.-S., Collet, J.-P., Silvain, J., Pena, A., Bellemain-Appaix, A., Barthélémy, O., Cayla, G., Beygui, F., & Montalescot, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.071 · Cited by 383
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS
Roth, R. B., Hevezi, P., Lee, J., Willhite, D., Lechner, S. M., Foster, A. C., & Zlotnik, A. (2006) · Neurogenetics · doi:10.1007/s10048-006-0032-6 · Cited by 342
Savi, P., & Herbert, J.-M. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869523 · Cited by 327
NISHIMURA, M., YAGUTI, H., YOSHITSUGU, H., NAITO, S., & SATOH, T. (2003) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.123.369 · Cited by 313
de Leon, J., Armstrong, S. C., & Cozza, K. L. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.1.75 · Cited by 300
Cytochrome P450 variations in different ethnic populations
McGraw, J., & Waller, D. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.657626 · Cited by 286
Preissner, S., Kroll, K., Dunkel, M., Senger, C., Goldsobel, G., Kuzman, D., Guenther, S., Winnenburg, R., Schroeder, M., & Preissner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp970 · Cited by 274
Self-citationHasler, J. A., Estabrook, R., Murray, M., Pikuleva, I., Waterman, M., Capdevila, J., Holla, V., Helvig, C., Falck, J. R., Farrell, G., et al. (1999) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(99)00005-9 · Cited by 267
Activation of procarcinogens by human cytochrome P450 enzymes
Peter Guengerich, F., & Shimada, T. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00037-2 · Cited by 260
Sim, S. C., & Ingelman-Sundberg, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-4-278 · Cited by 216
Sofi, F., Giusti, B., Marcucci, R., Gori, A. M., Abbate, R., & Gensini, G. F. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.21 · Cited by 172
Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption
Sulem, P., Gudbjartsson, D. F., Geller, F., Prokopenko, I., Feenstra, B., Aben, K. K. H., Franke, B., den Heijer, M., Kovacs, P. L., Stümvoll, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr086 · Cited by 145
Berka, K., Hendrychova, T., Anzenbacher, P., & Otyepka, M. (2011) · The Journal of Physical Chemistry A · doi:10.1021/jp204488j · Cited by 142
Cytochrome P450-Mediated Drug Interactions
Flockhart, D. A., & Oesterheld, J. R. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30135-4 · Cited by 129
The human genome project and novel aspects of cytochrome 450 research
Ingelman‐Sundberg, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.030 · Cited by 125
Biodiversity of cytochrome P450 redox systems
McLean, K. J., Sabri, M., Marshall, K., Lawson, R. J., Lewis, D. G., Clift, D., Balding, P. R., Dunford, A. J., Warman, A. J., McVey, J. P., et al. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330796 · Cited by 122
GeneSigDB—a curated database of gene expression signatures
Culhane, A. C., Schwarzl, T., Sultana, R., Picard, K. C., Picard, S., Lu, T. H., Franklin, K. R., French, S. J., Papenhausen, G., Correll, M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1015 · Cited by 96
The future (or lack of future) of personalized prescription in psychiatry
de León, J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.10.002 · Cited by 89
de León, J., Susce, M. T., Johnson, M., Hardin, M., Maw, L., Shao, A., Allen, A. C. P., Chiafari, F. A., Hillman, G. R., & Nikoloff, D. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900020022 · Cited by 88
Shalapour, S., Hof, J., Kirschner‐Schwabe, R., Bastian, L., Eckert, C., Prada, J., Henze, G., von Stackelberg, A., & Seeger, K. (2011) · Haematologica · doi:10.3324/haematol.2011.047993 · Cited by 78
Pharmacogenetics-Guided Dose Modifications of Antidepressants
Seeringer, A., & Kirchheiner, J. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2008.05.006 · Cited by 49
CYP2D6 and The Severity of Suicide Attempts
Peñas‐Lledó, E., Blasco-Fontecilla, H., Dorado, P., Vaquero‐Lorenzo, C., Baca‐García, E., & LLerena, A. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.146 · Cited by 44
Jounaïdi, Y., Chen, C.-S., Veal, G. J., & Waxman, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0321 · Cited by 44
Laine, K., l, J. K., & Bertilsson, L. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200412000-00016 · Cited by 38
Kassimis, G., Davlouros, P. A., Xanthopoulou, I., Stavrou, E. F., Athanassiadou, A., & Alexopoulos, D. K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.07.022 · Cited by 32
Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome
Dupont, A. G., Gabriel, D. A., & Cohen, M. G. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.01.014 · Cited by 30
Cytochrom-P450-Enzyme und ihre Bedeutung für Medikamenteninteraktionen
Papp-Jambor, C., Jaschinski, U., & Forst, H. (2002) · Der Anaesthesist · doi:10.1007/s101-002-8365-5 · Cited by 25
Huo, R., Tang, K., Wei, Z., Shen, L., Xiong, Y., Wu, X. L., Niu, J., Han, X., Tian, Z., Yang, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034809 · Cited by 21
The Role of Proximal Nephron in Cyclophosphamide-Induced Water Retention: Preliminary Data
Kim, S., Jo, C. H., Park, J.-S., Han, H. J., & Kim, G. (2011) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2011.9.1.7 · Cited by 12
Genotype and Phenotype Relationship in Drug Metabolism
Roots, I., Laschinski, G., Arjomand-Nahad, F., Kirchheiner, J., Schwarz, D., Brockmöller, J., Cascorbi, I., & Gerloff, T. (2007) · Springer eBooks · doi:10.1007/978-3-540-49529-1_6 · Cited by 8
Cited by
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Nutrient excess and autophagic deficiency: explaining metabolic diseases in obesity
van Niekerk, G., du Toit, A., Loos, B., & Engelbrecht, A.-M. (2018) · Metabolism · doi:10.1016/j.metabol.2017.12.007 · Cited by 34
Personalized Cancer Therapy Considering Cytochrome P450 Variability
Preissner, S., Simmaco, M., Gentile, G., & Preissner, R. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2015.03.004 · Cited by 12
Self-citation
Metadata
- Authors
- Preissner, S. C., Hoffmann, M. F., Preissner, R., Dunkel, M., Gewiess, A., & Preissner, S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-10
- Volume
- 8
- Issue
- 12
- Pages
- e82562
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2052934239
- Cited by
- 278
- References
- 50
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.